Anxiety symptoms in epilepsy: Salient issues for future research

Epilepsy and Behavior

Volumn 22, Issue 1, 2011, Pages 63-68

  Hamid, Hamada ^a   Ettinger, Alan B ^b   Mula, Marco ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Anxiety; Mood disorders; Neuroimaging

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; GLUTAMIC ACID;

ANXIETY DISORDER; ANXIETY STATUS INVENTORY; BECK ANXIETY INVENTORY; BEHAVIOR; CLINICAL ANXIETY SCALE; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE SOMATIC ANXIETY QUESTIONNAIRE; COVI ANXIETY RATING SCALE; DEPRESSION; DIFFUSION TENSOR IMAGING; EPILEPSY; GRAY MATTER; HAMILTON RATING SCALE FOR ANXIETY; HUMAN; HYPOTHESIS; LEARNING; MEDICAL RESEARCH; MOOD DISORDER; NEUROBIOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PATIENT ASSESSMENT; QUESTIONNAIRE; REVIEW; TREATMENT RESPONSE; WHITE MATTER;

AMYGDALA; ANXIETY; ANXIETY DISORDERS; BRAIN; BRAIN MAPPING; EPILEPSY; FRONTAL LOBE; HUMANS; NEURAL PATHWAYS;

EID: 80052476709     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.04.064     Document Type: Review

References (52)

1. Placidi G.P.A., Oquendo M.A., Malone K.M., Brodsky B., Ellis S.P., Mann J.J. Anxiety in major depression: relationship to suicide Attempts. Am J Psychiatry 2000, 157:1614-1618.
2. De Bianchedi E.T., Scalouzub De Boschan L., De Cortiñas L.P., De Piccolo E.G. Theories on anxiety in Freud and Melanie Klein: their metapsychological status. Int J Psychoanal 1988, 69(Pt. 3):359-368.
3. Ledoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
4. Stahl S.M. Brainstorms: symptoms and circuits: Part 2. Anxiety disorders. J Clin Psychiatry 2003, 64:1408-1409.
5. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 2004, 10:685-692.
6. Mula M., Pini S., Cassano G.B. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 2007, 27:263-272.
7. Mula M., Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 2009, 11:1-9.
8. Schwartz R.D. The GABAA receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem Pharmacol 1988, 37:3369-3375.
9. Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., Nutt D.J. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998, 55:715-720.
10. Chugh Y., Saha N., Sankaranarayanan A., Sharma P.L. Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats. Psychopharmacology (Berl) 1992, 106:127-130.
11. Saad S.F., Khayyal M.T., Attia A.S., Saad E.S. Influence of certain calcium-channel blockers on some aspects of lorazepam-dependence in mice. J Pharm Pharmacol 1997, 49:322-328.
12. Ettinger A.B., Weisbrot D.M., Nolan E.E., et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998, 39:595-599.
13. Mula M., Strigaro G. Clinical trials for anxiety disorders. Clinical trials in psychopharmacology: a better brain 2010, 191-206. Wiley, Chichester. 2nd ed. M. Hertzman, L. Adler (Eds.).
14. Barry J.J., Ettinger A.B., Friel P., et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008, 13:S1-S29.
15. Wilkinson G., Balestrieri M., Ruggeri M., Bellantuono C. Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders. Psychol Med 1991, 21:991-998.
16. Bandelow B., Seidler-Brandler U., Becker A., Wedekind D., Ruther E. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry 2007, 8:175-187.
17. Bakker A., van Balkom A.J., Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 2002, 106:163-167.
18. Van Balkom A.J., Bakker A., Spinhoven P., Blaauw B.M., Smeenk S., Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 1997, 185:510-516.
19. Furukawa T.A., Watanabe N., Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007, 1. [CD004364].
20. Fava M., Rush A.J., Trivedi M.H., et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003, 26:457-494.
21. McIntosh A.M., Wilson S.J., Berkovic S.F. Seizure outcome after temporal lobectomy: current research practice and findings. Epilepsia 2001, 42:1288-1307.
22. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62:258-261.
23. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45:544-550.
24. Pompili M., Girardi P., Tatarelli G., Angeletti G., Tatarelli R. Suicide after surgical treatment in patients with epilepsy: a meta-analytic investigation. Psychol Rep 2006, 98:323-338.
25. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., Meador K.J. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 2005, 17:172-179.
26. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4(Suppl. 3):S31-S38.
27. Hitiris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75:192-196.
28. Kanner A.M., Byrne R., Chicharro A., Wuu J., Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 2009, 72:793-799.
29. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004, 161:1957-1966.
30. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997, 9:471-481.
31. Mayberg H.S., Brannan S.K., Mahurin R.K., et al. Cingulate function in depression: a potential predictor of treatment response. NeuroReport 1997, 8:1057-1061.
32. Mayberg H.S. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 2009, 119:717-725.
33. Spencer S. Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia 2002, 43:219-227.
34. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003, 54:388-398.
35. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006, 59:35-41.
36. 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007, 68:364-368.
37. Theodore W.H., Hasler G., Giovacchini G., et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 2007, 48:1526-1530.
38. Savic I., Lindstrom P., Gulyas B., Halldin C., Andree B., Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62:1343-1351.
39. Giovacchini G., Toczek M.T., Bonwetsch R., et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial volume correction. J Nucl Med 2005, 46:1128-1135.
40. 18F MPPF PET study. Brain 2008, 131:2765-2782.
41. Satishchandra P., Krishnamoorthy E.S., van Elst L.T., et al. Mesial temporal structures and comorbid anxiety in refractory partial epilepsy. J Neuropsychiatry Clin Neurosci 2003, 15:450-452.
42. Bonelli S.B., Powell R., Yogarajah M., et al. Preoperative amygdala fMRI in temporal lobe epilepsy. Epilepsia 2009, 50:217-227.
43. Wrench J.M., Wilson S.J., Bladin P.F., Reutens D.C. Hippocampal volume and depression: insights from epilepsy surgery. J Neurol Neurosurg Psychiatry 2009, 80:539-544.
44. Halley S.A., Wrench J.M., Reutens D.C., Wilson S.J. The amygdala and anxiety after epilepsy surgery. Epilepsy Behav 2010, 18:431-436.
45. Fisher R., Salanova V., Witt T., et al. Electrical stimulation of anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010, 51:899-908.
46. Hamid H., Wang F., Qadri U., Spencer L., Mattson R., Blumberg H. Structural integrity of corticolimbic white matter associated with depression in temporal lobe epilepsy. Abstracts, American Neuropsychiatric Annual Meeting 2011.
47. Kanner A. Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?. Curr Neurol Neurosci Rep 2009, 4:307-312.
48. Jobe P.C. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 2003, 4(Suppl. 3):14-24.
49. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000, 47:305-313.
50. Cavus I., Pan J.W., Hetherington H.P., et al. Decreased hippocampal volume on MRI is associated with increased extracellular glutamate in epilepsy patients. Epilepsia 2008, 49:1358-1366.
51. Pan J.W., Venkatraman T., Vives K., Spencer D.D. Quantitative glutamate spectroscopic imaging of the human hippocampus. NMR Biomed 2006, 19:209-216.
52. Hamid H., Devinsky O., Vickrey B.G., et al. Suicide outcomes after resective epilepsy surgery. Epilepsy Behav 2011, 20:462-464.